Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 13, 2026, 9:07 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1369–1392 of 1,748 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Cardiovascular Risks Clear all

Conditions: Chronic Kidney Diseases, Hypertension, Blood Pressure
Interventions: strict blood pressure control; Other
Lead sponsor: University of California, San Francisco; Other
Eligibility: 13 Years to 30 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Cardiovascular Disease
Interventions: Decoding Your Diet; Genetic
Lead sponsor: Morehouse School of Medicine; Other
Eligibility: 40 Years to 70 Years
Enrollment: 15 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Hypertension, African Americans, Diet, Carbohydrate-Restricted, Risk Reduction Behavior
Interventions: Very low carbohydrate diet, Standard DPP-GLB diet, Standard DPP-GLB program modules; Other · Behavioral
Lead sponsor: Baylor Research Institute; Other
Eligibility: 18 Years to 74 Years
Enrollment: 64 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Hypertension
Interventions: Lifestyle interventions to lower blood pressure for patients, MD CQI-type intervention; Behavioral
Lead sponsor: Duke University; Other
Eligibility: 25 Years and older
Enrollment: 574 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2008
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Stroke, Hypertension, Diabete Mellitus, Dyslipidemias, Sleep Disorder, Smoking, Overweight and Obesity, Familial Alzheimer Disease, Atrial Fibrillation, Cardiac Disease, Cognitive Impairment, Transient Ischemic Attack
Interventions: DELPhI system; Device
Lead sponsor: QuantalX Neuroscience; Industry
Eligibility: 50 Years to 75 Years
Enrollment: 335 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2022
U.S. locations: 3
States / cities: Walnut Creek, California • Atlanta, Georgia • Norwood, Ohio

Conditions: Diabetes, Heart Failure
Interventions: Metformin; Drug
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years to 90 Years
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Posttraumatic Stress Disorder
Interventions: Cognitive processing therapy; Behavioral
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 65 Years
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Atrial Fibrillation, Risk Factors, Risk Reduction Behavior
Interventions: AliveCor mobile ECG cardiac monitor, AF Program, Standard of care; Other · Behavioral
Lead sponsor: Boston Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Obesity & Overweight
Interventions: GLP-1 Lifestyle Management Program, Enhanced Usual Care Health Education; Behavioral
Lead sponsor: University of Florida; Other
Eligibility: 30 Years to 79 Years
Enrollment: 670 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2032
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Acute Coronary Syndrome, Chest Pain
Interventions: OU - Cardiac MRI, OU - Conventional Care Testing; Other
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older
Enrollment: 124 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Cardiovascular Disease
Interventions: Strawberry Meal, Control Meal; Dietary Supplement
Lead sponsor: Penn State University; Other
Eligibility: 20 Years to 50 Years
Enrollment: 34 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: University Park, Pennsylvania

Conditions: Atherosclerosis, Hypercholesterolemia
Interventions: Statins, HMG CoA; Drug
Lead sponsor: National Heart, Lung, and Blood Institute (NHLBI); NIH
Eligibility: 50 Years to 99 Years
Enrollment: 230 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2017
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Cardiovascular Risk Factor
Interventions: Moderate Potassium/Low Sodium Diet, Moderate Potassium/High Sodium Diet, High Potassium/High Sodium Diet; Other
Lead sponsor: University of Delaware; Other
Eligibility: 22 Years to 45 Years
Enrollment: 47 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2019
U.S. locations: 1
States / cities: Newark, Delaware

Conditions: Cardiovascular Risk Factor
Interventions: Choline, Placebo; Dietary Supplement
Lead sponsor: Virginia Polytechnic Institute and State University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 29 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2023
U.S. locations: 1
States / cities: Blacksburg, Virginia

Conditions: Left Ventricular Dysfunction, Coronary Artery Disease
Interventions: Impella CP® / Impella CP® with SmartAssist® / Impella 2.5®, IABP Intra-aortic balloon pump; Device
Lead sponsor: Abiomed Inc.; Industry
Eligibility: 18 Years to 90 Years
Enrollment: 1,252 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2027
U.S. locations: 83
States / cities: Birmingham, Alabama • Phoenix, Arizona • Tucson, Arizona + 65 more

Conditions: Deep Venous Thrombosis, Pulmonary Embolism
Interventions: Not listed
Lead sponsor: US Department of Veterans Affairs; Federal
Eligibility: 18 Years and older
Healthy volunteers: Accepts healthy volunteers
Timeline: 1999 – 2003
U.S. locations: 1
States / cities: Denver, Colorado

Conditions: Hereditary Hemorrhagic Telangiectasia
Interventions: Not listed
Lead sponsor: Unity Health Toronto; Other
Eligibility: Not listed
Enrollment: 2,272 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2025
U.S. locations: 14
States / cities: Phoenix, Arizona • Little Rock, Arkansas • Los Angeles, California + 11 more

Conditions: Heart Arrest
Interventions: Respiratory & Heart Rate Data Collection; Other
Lead sponsor: University of Chicago; Other
Eligibility: 18 Years and older
Enrollment: 133 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Venous Thromboembolism, Deep Vein Thrombosis, Neoplasms
Interventions: Rosuvastatin, Placebo; Drug
Lead sponsor: University of Vermont; Other
Eligibility: 18 Years and older
Enrollment: 38 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2016
U.S. locations: 1
States / cities: Burlington, Vermont

Conditions: Cardiac Decompensation
Interventions: Not listed
Lead sponsor: Aventyn, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 51 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 2
States / cities: Mineola, New York • Roslyn, New York

Conditions: Prediabetic State, Cardiovascular Diseases, Insulin Resistance, Obesity
Interventions: Low/Mod, High/Mod, High/Vig; Behavioral
Lead sponsor: Duke University; Other
Eligibility: 60 Years to 90 Years
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Pulmonary Arterial Hypertension
Interventions: Sotatercept, Placebo; Drug · Other
Lead sponsor: Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 173 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 26
States / cities: Phoenix, Arizona • Los Angeles, California • Orange, California + 22 more

Conditions: Ischemic Cardiomyopathy, Nonischemic Cardiomyopathy
Interventions: Not listed
Lead sponsor: Johns Hopkins University; Other
Eligibility: 21 Years to 80 Years
Enrollment: 400 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2030
U.S. locations: 2
States / cities: Newark, Delaware • Baltimore, Maryland

Conditions: Cerebral Ischemia
Interventions: SANGUINATE™; Biological
Lead sponsor: Prolong Pharmaceuticals; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: St Louis, Missouri

Search by objective public record fields.

Pilot to Examine Risk and Feasibility of Remote Management of BP From Childhood Into Early Adulthood

Decoding Your Diet (DYD)

Giving a Low Carbohydrate Diet to Overcome Hypertension

Interventions to Improve Hypertension Control and Reduce Cardiovascular Disease Risk

DELPHI in Subjects at Risk for Stroke and Dementia

A Pilot Study: Metformin Therapy in Heart Failure Patients With Early Diabetes or at High Risk of Developing Diabetes (Pre-Diabetes)

Impact of Cognitive Behavioral Therapy on PTSD-CVD Link

Secondary Prevention of Atrial Fibrilation

Lifestyle Strategies to Preserve Muscle and Reduce Cardiovascular Risk in Adults With Obesity Using GLP-1 Receptor Agonists

Efficacy Evaluation of Observation Unit Cardiac Magnetic Resonance Imaging (MRI) in Patients With Intermediate Risk Acute Chest Pain

Effect of Strawberries on Cardiovascular Disease Risk

Randomized Trial of Imaging Versus Risk Factor-Based Therapy for Plaque Regression

Vascular Effects of Dietary Potassium

Choline Supplementation and Cardiovascular Health

Impella®-Supported PCI in High-Risk Patients With Complex Coronary Artery Disease and Reduced Left Ventricular Function

Risk Factors for Venous Thromboembolism

Cerebral Hemorrhage Risk in Hereditary Hemorrhagic Telangiectasia

Automated Respiration Rate to Improve Accuracy of the Electronic Cardiac Arrest Risk Triage Score (eCART) Algorithm

Detecting the Impact of Statin Therapy On Lowering Risk of Venous Thrombo-Embolic Events (DISOLVE)

Evaluate Heart Failure Patients With Specially Designed Patient Adherence and Monitoring Software on Standard Mobile Devices

Role of Aging and Individual Variation in Exercise Training Responsiveness

A Study of Sotatercept in Participants With PAH WHO FC III or FC IV at High Risk of Mortality (MK-7962-006/ZENITH)

Left Ventricular Structural Predictors of Sudden Cardiac Death

Safety and Effect of SANGUINATE™ Infusion in Patients at Risk of Delayed Cerebral Ischemia (DCI) Following Subarachnoid Hemorrhage (SAH)